Abstract:Background Genetic, clinical and experimental evidence has mounted to suggest the implication of gut dysbiosis in the pathogenesis of ankylosing spondylitis (AS) through the gut-joint axis of inflammation[1]. A series of cross-sectional studies have unraveled the alterations of gut microbiome composition in patients with AS using metagenome sequencing. However, such observational associations might be limited to the small sample sizes and the influences from confounders. Furthermore, whether gut dysbiosis is a cause or a consequence of AS remains elusive. Mendelian randomization (MR) is an epidemiologic approach for causal inference using genetic variants as instrument variables. Objectives To assess the causal relationship between gut bacteria taxa and risk of AS using two-sample MR. Methods To select instrument variables for gut bacteria taxa, we filtered genome-wide significant (p ≤ 5 x 10-8) and independent (r 2 < 0.01 within the window size of 500kb) variants for 211 taxa from a large-scale genome-wide association study (GWAS) on gut microbiota which included 18,340 individuals from 24 cohorts[2]. The summary statistics on AS from the UK Biobank (UKB) and the FinnGen consortium were utilized for the discovery and replication analyses, respectively[3]. Under the framework of two-sample MR, the inverse variance weighted method or the Wald ratio method was used to assess the causal effect of gut microbial taxa on risk of AS. In addition, multiple sensitivity analyses and reverse MR analyses were conducted to validate the robustness of results and evaluate reverse causation, respectively. Results Despite no taxa passing the multiple-testing correction, six known taxa were identified to have causal effects on the onset of AS in the UKB cohort at the nominal significance level (p < 0.05). In the FinnGen cohort, only one bacterial genus, Anaerotruncus was replicated (UKB: βIVW = -0.0016, p = 0.04; FinnGen: βIVW = -0.3990, p = 0.04). Sensitivity analyses led no support to the presence of heterogeneity (Q_p > 0.05) and pleiotropy (Intercept_p > 0.05). Reverse MR analysis found no reverse causality from AS to Anaerotruncus. Conclusion Despite no current evidence supporting the association between Anaerotruncus and AS, this study provides the first genetic evidence for the protective effect of this short-chain fatty acid (SCFA)-producer against AS. Intriguingly, several studies have suggested a relationship between Anaerotruncus and immune-mediated diseases including rheumatoid arthritis and inflammatory bowel diseases[4]. These MR findings shed light on the causative microbiota and microbiome-modulating strategies for AS. References [1]Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol 2021;43:173–92. doi:10.1007/s00281-021-00845-0 [2]Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 2021;53:156–65. doi:10.1038/s41588-020-00763-1 [3]S S, M K, Y T, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 2021;53. doi:10.1038/s41588-021-00931-x [4]Thomann AK, Wüstenberg T, Wirbel J, et al. Depression and fatigue in active IBD from a microbiome perspective-a Bayesian approach to faecal metagenomics. BMC Med 2022;20:366. doi:10.1186/s12916-022-02550-7 Acknowledgements We thank the researchers in the MiBioGen consortium, UK Biobank and FinnGen biobanks for releasing their valuable GWAS datasets. Disclosure of Interests None Declared.

AB0176 GENETIC EVIDENCE REVEALED A CAUSAL ROLE OF GUT MICROBIOTA IN POLYMYALGIA RHEUMATICA

Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis/dermatomyositis: a Mendelian randomization analysis

AB0153 GENETIC EVIDENCE SUPPORTS CAUSAL EFFECT OF GUT MICROBIOTA AND DERMATOMYOSITIS

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis

Causal relationship between gut microbiota and rheumatoid arthritis: a two-sample Mendelian randomisation study

Causal association between gut microbiota and fibromyalgia: a Mendelian randomization study

Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study

AB0089 MENDELIAN RANDOMIZATION REVEALS CAUSATIVE GUT BACTERIA FOR ANKYLOSING SPONDYLITIS

Investigating causal associations among gut microbiota, metabolites, and psoriatic arthritis: a Mendelian randomization study

AB0171 MENDELIAN RANDOMIZATION ANALYSIS REVEALS CAUSAL EFFECTS OF GUT MICROBIOTA ABUNDANCE ON GIANT CELL ARTERITIS RISK

Causal Associations Between 141 Gut Microbiota Taxa and 14 Rheumatic Diseases: A Mendelian Randomization Study

Causal relationship between gut microbiota and myasthenia gravis: a two-sample Mendelian randomization study

Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation

Exploring the causal relationship between gut microbiota and multiple myeloma risk based on Mendelian randomization and biological annotation

AB1237 ASSOCIATION OF GUT MICROBIOTA WITH RISK OF GOUT

AB0160 GUT MICROBES AND SYSTEMIC SCLEROSIS: CAUSE OR CONSEQUENCE?

Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study

The influence of gut microbiota on membranous nephropathy: A two-sample Mendelian randomization study

Causal relationships between gut microbiota and polycystic ovarian syndrome: A bidirectional Mendelian randomization study

Large-scale bidirectional Mendelian randomization study identifies new gut microbiome significantly associated with immune thrombocytopenic purpura